MISVENOL

Capsule, hard, 12.5mg
RxActive license

Active substance (INN)

sunitinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength12.5mg
PackagingUkupno 28 kapsula tvrdih u blisteru (2x14) u kartonskoj kutiji
ManufacturerGenepharm S.A., Greece
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holder"GLK PHARMA" DRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU, PODGORICA
Authorization dateDecember 21, 2022

Analogs in Montenegro

20

Other medicines with the same active substance

FASINDORRestricted
Capsule, hard, 50mgAlkaloid AD Skopje
FASINDORRx
Capsule, hard, 12.5mgAlkaloid AD Skopje
FASINDORRx
Capsule, hard, 25mgAlkaloid AD Skopje
MISVENOLRx
Capsule, hard, 25mgGenepharm S.A.
MISVENOLRx
Capsule, hard, 50mgGenepharm S.A.
SUNITINIB PLIVARestricted
Capsule, hard, 50 mgTeva Operations Poland Sp. z o.o.
SUNITINIB PLIVARestricted
Capsule, hard, 25 mgTeva Operations Poland Sp. z o.o.
SUNITINIB PLIVARestricted
Capsule, hard, 12.5 mgTeva Operations Poland Sp. z o.o.
SUNITINIB SANDOZRx
Capsule, hard, 12.5mgLek farmacevtska družba d.d. (Lek Pharmaceuticals d.d.)
SUNITINIB SANDOZRx
Capsule, hard, 25mgLek farmacevtska družba d.d. (Lek Pharmaceuticals d.d.)
SUNITINIB SANDOZRx
Capsule, hard, 50mgLek farmacevtska družba d.d. (Lek Pharmaceuticals d.d.)
SUNITINIB ZENTIVARx
Capsule, hard, 25mgRemedica Ltd.
SUNITINIB ZENTIVARx
Capsule, hard, 50mgRemedica Ltd.
SUNITINIB ZENTIVARx
Capsule, hard, 12.5mgRemedica Ltd.
SUNITINIB ZENTIVARx
Capsule, hard, 25mgRemedica Ltd.
SUNITINIB ZENTIVARx
Capsule, hard, 50mgRemedica Ltd.
SUNITINIB ZENTIVARx
Capsule, hard, 12.5mgRemedica Ltd.
SUTENTRx
Capsule, hard, 25mgPfizer Italia S.r.l.
SUTENTRx
Capsule, hard, 50mgPfizer Italia S.r.l.
SUTENTRx
Capsule, hard, 12.5mgPfizer Italia S.r.l.
Source: CInMED register